Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib
Abstract Tyrosine kinase inhibitors are effective as a target therapy for malignant neoplasms. Imatinib was the first tyrosine kinase inhibitor used. After its introduction, several other drugs have appeared with a similar mechanism of action, but less prone to causing resistance. Even though these...
Saved in:
Main Authors: | Juliana Ribeiro Leitão (Author), Neusa Yuriko Sakai Valente (Author), Priscila Kakizaki (Author), Isis Suga Veronez (Author), Mario Cezar Pires (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features
by: Carolina Oliveira Costa Fechine, et al.
Published: (2022) -
Possibly drug-induced palpable migratory arciform erythema
by: Fernando Luiz Teixeira Dantas, et al.
Published: (2015) -
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
by: Hari Krishna Ananthula, et al.
Published: (2018) -
Second-generation Tyrosine Kinase Inhibitors Nilotinib- and Dasatinib-induced Keratosis Pilaris: A Case Report and Review of the Literature
by: Hussein M. Alshamrani, et al.
Published: (2024) -
Lichen planopilaris developed during childhood
by: Heliana Freitas de Oliveira Góes, et al.
Published: (2017)